thank - you for the responses above - I guess my next steps is to try and value (DCF) the nuclear technology and see whether it comes close to the present market cap. i.e what do its revenue streams look like (milestone payments, etc ?
If the market cap can be justified on the basis of nuclear - then solar becomes a free option, and the company may be investment grade. If it doesn't then it is an extremely risky investment given the lack of underlying earnings and the relatively high market cap.
i, and others I know, have a great deal of experience in assessing solar thin film vs silicon etc, installation of the alternative power technology, thermal efficiency etc and it is a very difficult gig, with some very substantial competitors (see First Solar for example) - it is not immediately apparent what competitive advantage Silex will have by manufacturing in Australia. 25% efficiency sounds almost nirvana like ...
thanks again, SITM
ps this is not investment advice and do not follow or rely on anything I have written
- Forums
- ASX - By Stock
- running scared
thank - you for the responses above - I guess my next steps is...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLX (ASX) to my watchlist
|
|||||
Last
$5.17 |
Change
-0.010(0.19%) |
Mkt cap ! $1.224B |
Open | High | Low | Value | Volume |
$5.18 | $5.20 | $5.10 | $1.179M | 229.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1277 | $5.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.17 | 1821 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1277 | 5.130 |
2 | 7136 | 5.120 |
1 | 1277 | 5.110 |
1 | 1277 | 5.100 |
1 | 5000 | 5.090 |
Price($) | Vol. | No. |
---|---|---|
5.170 | 1821 | 1 |
5.190 | 3115 | 2 |
5.200 | 1277 | 1 |
5.210 | 1277 | 1 |
5.220 | 2277 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
SLX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online